4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-047821
President and CEO sold 4,807 shares at $12.09 ($58,117)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Touchon Pascal President and CEO | 2020-08-18 | Sale | −4,807 | $12.09 | $58,117 | 260,037 | D: show line 1 in the form |
| Open-market sales · 4,807 sh · avg $12.09 · $58,117 | |||||||
Loading xslF345X03/doc4.xml…